Skip to search formSkip to main contentSkip to account menu

zoledronate

Known as: (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid, [1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic Acid, NDC-Zoledronate 
The brand name for zoledronic acid, a bisphosphonic imidazol compound which inhibits osteoclastic bone resorption. Although its mechanisms of action… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Sleep apnea is associated with increased cardiovascular risk and may be important in atrial fibrillation (AF) management. It is… 
Highly Cited
2005
Highly Cited
2005
Although imatinib mesylate has revolutionized the treatment of chronic myeloid leukaemia (CML), resistance to the drug… 
Highly Cited
2005
Highly Cited
2005
Prostate cancer cells metastasize to the bone where their interaction with osteoclasts and osteoblasts can lead to alterations in… 
Highly Cited
2004
Highly Cited
2004
Breast cancer has a significant capacity to metastasize to bone. Bisphosphonates are the standard treatment for hypocalcaemia of… 
2004
2004
Clinical practice reveals that osteoporotic women treated with BPs (bisphosphonates) show an increased bone mass density and a… 
Highly Cited
2000
Highly Cited
2000
Bisphosphonates (BPs) are commonly used in the treatment of myeloma-associated osteolytic lesions. Recent reports have suggested… 
1993
1993
Liarozole fumarate (R85,246), a novel benzimidazole derivative, reduced s.c. and bone metastasis tumor growth by the androgen…